Meeting report, Kampala, Uganda,
7–8 November 2023
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                        Strengthening of SDB teams through refresher trainings and regular simulation exercises/drills
        Continue social mobilization and community engagement through mobile cinema and community awareness sessions
        Procure and preposition additional PPE kits
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Abbreviated Report of a WHO Consultation
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                A pocket atlas for clinical health-care professionals
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                 Global HIV Strategic Information Working Group
For Populations At Risk For HIV
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Updated Treatment Guidelines